Genpact (NYSE:G - Get Free Report) will likely be announcing its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Genpact to post earnings of $1.04 per share and revenue of $1.38 billion for the quarter. Investors are encouraged to explore the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Tuesday, June 30th. The business services provider reported $1.00 EPS for the quarter. The business had revenue of $1.34 billion during the quarter. Genpact had a return on equity of 23.34% and a net margin of 11.04%. On average, analysts expect Genpact to post $3.66 EPS for the current fiscal year and $4.07 EPS for the next fiscal year.
Genpact Stock Performance
NYSE G opened at $38.78 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.00 and a quick ratio of 2.00. The company has a market cap of $6.48 billion, a P/E ratio of 11.51, a P/E/G ratio of 1.09 and a beta of 0.57. The stock has a 50-day moving average of $36.06 and a two-hundred day moving average of $35.74. Genpact has a 1-year low of $26.85 and a 1-year high of $48.64.
Genpact Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 23rd. Stockholders of record on Thursday, December 10th will be given a dividend of $0.1875 per share. This represents a $0.75 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Thursday, December 10th. Genpact's dividend payout ratio is currently 22.26%.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on G shares. Deutsche Bank Aktiengesellschaft set a $31.00 price objective on shares of Genpact in a report on Friday, July 10th. Robert W. Baird reduced their target price on shares of Genpact from $45.00 to $38.00 and set a "neutral" rating on the stock in a report on Tuesday, July 7th. Citigroup raised their price target on shares of Genpact from $32.00 to $36.00 and gave the company a "neutral" rating in a research report on Friday, August 7th. Susquehanna boosted their price target on shares of Genpact from $37.00 to $40.00 and gave the stock a "neutral" rating in a research note on Thursday, October 22nd. Finally, Needham & Company LLC dropped their price target on shares of Genpact from $50.00 to $45.00 and set a "buy" rating for the company in a research note on Friday, August 7th. Two research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $39.67.
Check Out Our Latest Stock Report on G
Insider Activity at Genpact
In other news, SVP Anil Nanduru sold 6,191 shares of the company's stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $37.03, for a total value of $229,252.73. Following the completion of the sale, the senior vice president directly owned 70,253 shares of the company's stock, valued at approximately $2,601,468.59. This represents a 8.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.58% of the stock is owned by insiders.
About Genpact
(
Get Free Report)
Genpact NYSE: G is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.
Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.